47-year-old mother-of-two Kate Harper was diagnosed with HER2+ breast cancer in 2017. Following chemotherapy and trastuzumab-based therapy, she has commenced NERLYNX therapy. She has continued working throughout her treatment. Click on the image banner above to play the video.